Surgeons at Stanford Medicine specializing in breast surgery are the pioneers in the nation to implement an innovative technology that highlights remaining cancer cells following tumor excision. Irene Wapnir, who utilizes this system for lumpectomy cases, clarifies its functionality – and its implications for patients.